Home NDC 70518-3702 Cyclobenzaprine hydrochloride
Product NDC 70518-3702
11-digit product format 705183702
Labeler code 70518
Product ID 70518-3702_56422575-8cd5-af33-e063-6294a90a8958
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Cyclobenzaprine hydrochloride
Dosage form TABLET, FILM COATED
Route ORAL
Labeler REMEDYREPACK INC.
Application ANDA213324
Marketing category ANDA
Marketing start 2023-04-06
Substance CYCLOBENZAPRINE HYDROCHLORIDE
Active strength 10 mg/1
Pharmacologic classes Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 13 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 117 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 84e616aacf4f…2026-08-18 06:07:40 2026-07 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A213324-002 CYCLOBENZAPRINE HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2020-07-06 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A213324-003 CYCLOBENZAPRINE HYDROCHLORIDE 10MG TABLET / ORAL AB 2020-07-05 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A213324-001 CYCLOBENZAPRINE HYDROCHLORIDE 5MG TABLET / ORAL AB 2020-07-06 301d65b070ca…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 117 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Cyclobenzaprine hydrochloride
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CYCLOBENZAPRINE HYDROCHLORIDE 10 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 0VE05JYS2P Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 828348 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70518-3702-0 Cyclobenzaprine hydrochloride 60 in 1 BOTTLE, PLASTIC TABLET, FILM COATED 60 9 70518-3702-1 Cyclobenzaprine hydrochloride 30 in 1 BLISTER PACK TABLET, FILM COATED 30 9 70518-3702-2 Cyclobenzaprine hydrochloride 90 in 1 BOTTLE, PLASTIC TABLET, FILM COATED 90 9 70518-3702-3 Cyclobenzaprine hydrochloride 30 in 1 BOTTLE, PLASTIC TABLET, FILM COATED 30 9
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 70518-3702 CYCLOBENZAPRINE HYDROCHLORIDE TABLET, FILM COATED [REMEDYREPACK INC.] 5 Current NDC, 4 package rows 20241027_51d85ea8-8317-4a76-a108-20383f118ad4.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 2 of 2 · 24 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 70518-3702-0 70518370200 60 in 1 BOTTLE, PLASTIC Historical 70518-3702-1 70518370201 30 TABLET, FILM COATED in 1 BLISTER PACK (70518-3702-1) 2023-04-12 No No Current 70518-3702-2 70518370202 90 in 1 BOTTLE, PLASTIC Historical 70518-3702-3 70518370203 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-3702-3) 2024-05-04 No No Current